IRIS
UGONE, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 502
EU - Europa 197
AS - Asia 110
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 501
UA - Ucraina 103
CN - Cina 83
DE - Germania 33
IT - Italia 26
SE - Svezia 19
KR - Corea 13
TR - Turchia 13
FI - Finlandia 8
GB - Regno Unito 5
PL - Polonia 2
AU - Australia 1
BR - Brasile 1
EU - Europa 1
JM - Giamaica 1
NG - Nigeria 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 813
Salva come PNG Salva come JPEG
Città #
Chandler 183
Jacksonville 58
Princeton 46
Dearborn 30
Wilmington 18
Nanjing 17
Mountain View 14
Izmir 13
Seoul 13
Jiaxing 8
Nanchang 8
Tianjin 8
Changsha 7
Shenyang 6
Beijing 5
Quartucciu 5
Sassari 5
Hebei 4
San Francisco 4
Ashburn 3
Cagliari 3
Kunming 3
Norwalk 3
Quartu Sant'elena 3
Taizhou 3
Zhengzhou 3
Ann Arbor 2
Boardman 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Helsinki 2
Jinan 2
Parma 2
Taiyuan 2
Abuja 1
Berlin 1
Bratislava 1
Canberra 1
Clearwater 1
Hefei 1
Lanzhou 1
London 1
Ningbo 1
Patos de Minas 1
Redwood City 1
Riyadh 1
Seattle 1
Tappahannock 1
Warsaw 1
Washington 1
Totale 507
Salva come PNG Salva come JPEG
Nome #
Speciation of potential anti-diabetic vanadium complexes in real serum samples 52
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 52
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 52
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 48
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 47
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 47
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 44
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 43
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 40
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 39
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability 39
Covalent and non-covalent binding in vanadium–protein adducts 37
Decoding Surface Interaction of VIVO Metallodrug Candidates with Lysozyme 36
Synthesis, crystal structures, EPR and DFT studies of first row transition metal complexes of lignin model compound ethylvanillin 34
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 30
VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins 29
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 28
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 26
VIVO and VIVSpecies Formed in Aqueous Solution by the Tridentate Glutaroimide–Dioxime Ligand – An Instrumental and Computational Characterization 26
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 24
Influence of temperature on the equilibria of oxidovanadium(IV) complexes in solution 24
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 22
Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands 20
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 14
Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c 10
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 2
Totale 865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 1 39
2019/2020145 30 0 6 0 15 22 40 1 15 1 15 0
2020/2021126 15 0 15 0 16 4 23 9 23 21 0 0
2021/2022123 11 0 0 0 9 0 1 12 9 20 9 52
2022/2023303 27 41 6 45 27 40 0 39 54 6 12 6
2023/202466 9 13 3 3 21 2 0 1 1 0 13 0
Totale 865